🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective open-label, single-arm, single-center clinical ...
Status
Recruiting
Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-06-21
Trial ID
NCT05747729
Treatments Being Tested
A phase II study to assess the efficacy and safety of Surufatinib or Surufa...
Status
Active Not Recruiting
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2020-06-03
Trial ID
NCT04922658
Treatments Being Tested
Prior clinical trials have demonstrated promising efficacy and manageable s...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2026-09-01
Trial ID
NCT07780539
Treatments Being Tested
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Status
Completed
Location
Zhejiang Province Cancer Hospital
Start Date
2022-07-01
Trial ID
NCT06378580
Treatments Being Tested
To evaluate the efficacy of Surufatnib combined with Toripalimab compared w...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-09-18
Trial ID
NCT05015621
Treatments Being Tested
To evaluate the efficacy and safety of surufatinib combined with gemcitabin...
Status
Not Yet Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-06-01
Trial ID
NCT06361030
Treatments Being Tested
A phase II, muti-cohort study to assess the efficacy and safety of Surufati...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04734249
Treatments Being Tested
This is a single-center, prospective, two cohort study to evaluate the effi...
Status
Recruiting
Location
Fudan University ShangHai Cancer Center
Start Date
2023-12-05
Trial ID
NCT05969171
Treatments Being Tested
This is an open-label, phase I study evaluating safety, tolerability, pharm...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-12-21
Trial ID
NCT03879057
Treatments Being Tested